Physician profile
Nam Phan Ho
NPI 1730344185
$5,392.99
in general payments reported to CMS, 2019-2025
34 companies · $962 in 2025
The $962 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $884 · 2020: $673 · 2021: $765 · 2022: $442 · 2023: $497 · 2024: $1,170 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,628.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $751.57 | 2019-2025 | Evenity, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $570.76 | 2019-2025 | Farxiga, Lokelma, Breztri |
| Novo Nordisk INC | $545.95 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $402.70 | 2019-2025 | Mounjaro, Jardiance, Kisunla |
| Gilead Sciences, INC. | $318.33 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.92 | 2019-2025 | Jardiance |
| Sumitomo Pharma America, INC. | $246.57 | 2023-2025 | Gemtesa |
| Pfizer INC. | $237.81 | 2019-2025 | |
| Glaxosmithkline, LLC. | $232.44 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $201.03 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Nestle Healthcare Nutrition INC. | $185.28 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $176.14 | 2021-2024 | |
| Astellas Pharma US INC | $164.60 | 2019-2023 | Myrbetriq |
| Exact Sciences Corporation | $147.94 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $125.41 | 2019-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $114.77 | 2019-2022 | |
| Abbott Laboratories | $80.28 | 2022-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $73.17 | 2024-2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $67.04 | 2023-2024 | Rexulti |
| Medtronic, INC. | $62.44 | 2025 | Minimed 780g |
| Corium, LLC | $62.38 | 2023 | Adlarity |
| Eisai INC. | $58.09 | 2021-2025 | |
| Lundbeck LLC | $44.63 | 2024-2025 | Rexulti |
| Axonics, INC. | $35.57 | 2023 | Axonics |
| Sanofi-Aventis U.S. LLC | $35.03 | 2019-2020 | |
| Sanofi Pasteur INC. | $29.81 | 2019-2023 | |
| Mylan Specialty L.P. | $29.00 | 2024 | Yupelri |
| Aimmune Therapeutics, INC. | $22.73 | 2025 | Zenpep |
| Hikma Pharmaceuticals USA | $18.62 | 2019 | |
| Scilex Pharmaceuticals INC. | $16.11 | 2020 | |
| Dynavax Technologies Corporation | $14.73 | 2019 | |
| Celgene Corporation | $14.63 | 2019 | |
| Radius Health, INC. | $14.17 | 2022 | |
| Allergan, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nam Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.